No products in the cart.
Pre-made Igovomab benchmark antibody (Radiolabelled antibody, anti-MUC16 therapeutic antibody, Anti-CA125 Antibody) for drug discovery and mechanism of action (MOA) research
Cat:GMP-Bios-INN-861
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
Product Details
Pre-made Igovomab benchmark antibody (Radiolabelled antibody, anti-MUC16 therapeutic antibody, Anti-CA125 Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Indium (111In) igovomab (trade name Indimacis-125) was a mouse monoclonal antibody for the diagnosis of ovarian cancer.[citation needed]
| Products Name (INN Index) | Pre-Made Igovomab Biosimilar, Radiolabelled Antibody, Anti-Muc16 Antibody: Anti-CA125 therapeutic antibody |
|---|---|
| INN Name | igovomab |
| Target | MUC16 |
| Format | Radiolabelled antibody |
| Derivation | Mus musculus |
| Species Reactivity | Human |
| CH1 Isotype | F(ab')2 – G1 – nd |
| VD LC | F(ab')2 – G1 – nd |
| Highest_Clin_Trial (Jan '20) | NA |
| Est. Status | NA |
| 100% SI Structure | NA |
| 99% SI Structure | NA |
| 95-98% SI Structure | NA |
| Year Proposed | NA |
| Year Recommended | NA |
| Companies | CIS?Bio international (Bagnols/C France) |
| Conditions Approved | NA |
| Conditions Active | NA |
| Conditions Discontinued | NA |
| Development Tech | NA |
| Previous Name | NA |
| Gm Offical Target Name | MUC16 |
| Package |
Previous slide
Next slide
